Research & Development, Sun Pharmaceutical Industries Ltd, pharmaceutical business development.#Pharmaceutical #business #development

Posted On Apr 19 2018 by

Research Development We were pioneers among Indian pharmaceutical companies to see tremendous value in investing in research development (R D). Our early investments in R D, beginning three decades ago, enabled us to make technology our key differentiator and develop a basket of robust products for diverse markets across the world. Our core strength lies in our ability to excel in developing generics and technologically complex products through focused teams in formulations, process chemistry and analytical development. We have the capability to deliver quality products within established timelines, at low costs and without compromising on quality. We have around 2000 …


Active Pharmaceutical Ingredients Research & Development, pharmaceutical development.#Pharmaceutical #development

Posted On Apr 9 2018 by

Latest @ Ipca Ipca – Ratlam formulations plant ranked third position in the National Energy Conservation Award – 2010. Active Pharmaceutical Ingredients (APIs) Division The Active Pharmaceutical Ingredients (APIs) / Drug Intermediates Research and Development Department at Mumbai is supported by two more well equipped units located at Ratlam and Indore. These R D units are also recognized by the Department of Science and Industrial Research, Government of India and are supported by facilities required for scale up of the processes from grams to kilo as well as to Pilot Plant level. The major activities of the division include: Process …


PharmTech Home, pharmaceutical development.#Pharmaceutical #development

Posted On Apr 9 2018 by

pharmaceutical development Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases Using Human Challenge Trials to Develop Flu Vaccines Moving to Closed Systems for Aseptic Processing Cold Chain: Delivering Vaccines to Patients Accelerating Vaccine Development and Manufacturing Achieving Intensification and Flexibility in Virus Purification with N. Operational Best Practices Your Online Resource to Global Suppliers Top News EMA to Relocate to New HQ in Amsterdam in Wake of Brexit Nov 21, 2017 Following a vote by member states in favor of Amsterdam as the agency’s new headquarters, the relocation will take place over the next 16 months, with operations expected to …


Pharmaceutical Technology, pharmaceutical product development.#Pharmaceutical #product #development

Posted On Mar 13 2018 by

pharmaceutical product development Pharmaceutical Technology is using cookies We use them to give you the best experience. If you continue using our website, we’ll assume that you are happy to receive all cookies on this website. Log In Clinical Trials LIFNano: can nanotech ‘flip the switch’ to cure multiple sclerosis? Red sage: could this ancient Chinese herb prevent bone loss? Nutraceuticals are being held back by regulatory confusion Cold Chain Evocalcet faces stiff competition in Japan’s CKD-induced hyperparathyroidism market Blockchain in pharma: opportunities in the supply chain Are drug expiration dates fit for purpose? Diseases LIFNano: can nanotech ‘flip the …


Pharmaceutical Analysis, pharmaceutical product development.#Pharmaceutical #product #development

Posted On Mar 13 2018 by

Pharmaceutical Analysis Specialist pharmaceutical analysis services to support development programs (R ?>


BUSINESS DEVELOPMENT, Sun Pharmaceutical Industries Ltd, business development pharma.#Business #development #pharma

Posted On Mar 9 2018 by

BUSINESS DEVELOPMENT With global revenues of US$ 4.5 billion, Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world. We provide high-quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries worldwide. Sun Pharma is also India’s largest and most trusted pharmaceutical company. Our global presence is supported by more than 40 manufacturing facilities across 5 continents. In the US market, which contributes a significant share of our revenues, we are the leader in the generic dermatology segment. We have strong capabilities in developing generic and complex products with a robust pipeline of 151 …


World Business Council For Sustainable Development (WBCSD), pharmaceutical business development.#Pharmaceutical #business #development

Posted On Feb 15 2018 by

pharmaceutical business development Stay on top of our latest news by subscribing to our Sustain newsletter World Business Council for Sustainable Development


Pharmaceutical Development: ICH, pharmaceutical development.#Pharmaceutical #development

Posted On Feb 9 2018 by

Pharmaceutical Development Finalised Guideline: The core tripartite harmonised ICH Guideline was finalised under Step 4 in November 2005. This Guideline is intended to provide guidance on the contents of Section 3.2.P.2 (Pharmaceutical Development) for drug products as defined in the scope of Module 3 of the Common Technical Document (ICH topic M4). The guideline does not apply to contents of submissions for drug products during the clinical research stages of drug development. However the principles in this guideline are important to consider during these stages. This guideline might also be appropriate for other types of products. To determine the applicability …


Pharmaceutical Drug Development Services, pharmaceutical development.#Pharmaceutical #development

Posted On Feb 9 2018 by

pharmaceutical development Experienced multi-disciplinary team providing flexible service options to deliver cost-effective and pragmatic development of pharmaceutical products to Phase 2b. S2PD supports clients in the following areas: Drug Development Planning Project Management S2PD has an experienced in-house drug development team to help clients with preclinical and early stage clinical phases. Our extensive experience in the space enables us to formulate plans and anticipate potential contingencies required. We know that work is often outsourced at short-notice with tight deliverable deadlines and sometimes with limited resources. S2PD will work with clients to define timelines, scope and resources required. Drug Candidate Selection …


UPM Pharmaceuticals – Formulation Development, CDMO, pharmaceutical formulation development.#Pharmaceutical #formulation #development

Posted On Jan 22 2018 by

pharmaceutical formulation development Proof of Concept Proof of Concept Proof of concept services at UPM are widely recognized for speed, precision and innovative thought across a full spectrum of studies. Based on our client needs, we evaluate a number of parameters for development and manufacture of specific API (active pharmaceutical ingredient) dosage forms based. Brevi-Batch is a cost effective development approach ideal for clients in search of high quality, proof of concept. With a significantly smaller scale than most small-scale R D formulation batches, Brevi-Batch conserves valuable R D API using equipment designed for fast set-up, use, and clean-up. UPM’s …